Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 9, 2009 - Issue 3
Submit an article Journal homepage
317
Views
42
CrossRef citations to date
0
Altmetric
Review

Autoimmune myasthenia gravis

Nils Erik Gilhus Department of Clinical Medicine, University of Bergen, and Department of Neurology, Haukeland University Hospital, 5021 Bergen, Norway. [email protected]
Pages 351-358 | Published online: 09 Jan 2014

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Aliona Nacu, Jintana Bunpan Andersen, Vitalie Lisnic, Jone Furlund Owe & Nils Erik Gilhus. (2015) Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 48:6, pages 362-368.
Read now
Jan J. G. M. Verschuuren, Jackie Palace & Nils Erik Gilhus. (2010) Clinical aspects of myasthenia explained. Autoimmunity 43:5-6, pages 344-352.
Read now
Kathleen Vrolix, Judith Fraussen, Peter C. Molenaar, Mario Losen, Veerle Somers, Piet Stinissen, Marc H. De Baets & Pilar Martínez-Martínez. (2010) The auto-antigen repertoire in myasthenia gravis. Autoimmunity 43:5-6, pages 380-400.
Read now

Articles from other publishers (39)

Sohyeon Kim, Ki Hoon Kim, Hye Yoon Chung, Hyung Jun Park, Young-Chul Choi, Ha Young Shin & Seung Woo Kim. (2022) Anti-titin antibodies are associated with myocarditis in patients with myasthenia gravis. Journal of Neurology 270:3, pages 1457-1465.
Crossref
Hiroyuki Murai, Kimiaki Utsugisawa, Masakatsu Motomura, Tomihiro Imai, Akiyuki Uzawa & Shigeaki Suzuki. (2023) The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome. Clinical and Experimental Neuroimmunology 14:1, pages 19-27.
Crossref
Shingo Konno, Takafumi Uchi, Jun Isonishi, Mari Matsushima, Hideo Kihara, Hideki Sugimoto & Toshiki Fujioka. (2022) Development of infections among patients with myasthenia gravis undergoing immunotherapy. Clinical and Experimental Neuroimmunology 14:1, pages 34-43.
Crossref
Kana Tamaki, Yoichiro Nishida, Nobuo Sanjo & Takanori Yokota. (2021) A patient with generalized myasthenia gravis facing an impending crisis triggered by early fast‐acting treatment. Clinical and Experimental Neuroimmunology 13:2, pages 99-101.
Crossref
Xin-tao Yu, Lei Yu, Xin Du, Zhen Yu, Xing-guo Yang & Yu-xuan Jiang. (2022) Clinical and Genetic Characteristics of Thymoma Patients With Autoimmune Hepatitis and Myocarditis. Frontiers in Oncology 11.
Crossref
Xiaoyin Lai, Zhuajin Bi, Xuelian Yang, Rongguo Hu, Lu Wang, Mingming Jin, Longxuan Li & Bitao Bu. (2021) Upregulation of circ‐FBL promotes myogenic proliferation in myasthenia gravis by regulation of miR‐133/PAX7. Cell Biology International 45:11, pages 2287-2293.
Crossref
Kenneth R. DeVault & Sami R. Achem. 2021. The Esophagus. The Esophagus 804 853 .
Jie Lv, Lu Ren, Sensen Han, Jing Zhang, Xue Zhao, Yingna Zhang, Hua Fang, Linyuan Zhang, Haonan Yang, Shumin Wang, Junhong Yang, Xinzheng Cui, Qingyong Zhang, Yunke Zhang & Feng Gao. (2021) Peripheral blood hsa-circRNA5333-4: A novel biomarker for myasthenia gravis. Clinical Immunology 224, pages 108676.
Crossref
Kimiaki Utsugisawa, Yuriko Nagane, Akiyuki Uzawa, Hiroyuki Murai, Tomihiro Imai & Shigeaki Suzuki. (2020) Health‐related quality of life and treatment strategies in myasthenia gravis. Clinical and Experimental Neuroimmunology 11:4, pages 209-217.
Crossref
Yoshihiko Isshiki, Osamu Mimura & Fumi Gomi. (2020) Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis. Japanese Journal of Ophthalmology 64:6, pages 628-634.
Crossref
Jonathan Hindmarsh, Elizabeth Woods, Mark Lee & Jonathan Pickard. (2019) Administering Neostigmine as a Subcutaneous Infusion: A Case Report of a Patient Dying With Myasthenia Gravis. Journal of Palliative Care 35:2, pages 78-81.
Crossref
Mi-Chu Lin, Ming-Hsien Tsai, Jyh-Gang Leu & Yu-Wei Fang. (2019) Hyperkalemia in a patient with myasthenia gravis: case presentation. BMC Endocrine Disorders 19:1.
Crossref
Timothy Liang, Mark I. Boulos, Brian J. Murray, Sridhar Krishnan, Hans Katzberg & Karthikeyan Umapathy. (2019) Analysis of electrooculography signals for the detection of Myasthenia Gravis. Clinical Neurophysiology 130:11, pages 2105-2113.
Crossref
Tomihiro Imai. (2019) Why is development of new treatments necessary for myasthenia gravis? Recent advances in clinical trials. Neurology and Clinical Neuroscience 7:4, pages 161-165.
Crossref
S. Jayashree, K. Nirekshana, Gunjan Guha & Dipita Bhakta-Guha. (2018) Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection. Biomedicine & Pharmacotherapy 102, pages 894-911.
Crossref
Tomihiro Imai, Kimiaki Utsugisawa, Hiroyuki Murai, Emiko Tsuda, Yuriko Nagane, Yasushi Suzuki, Naoya Minami, Akiyuki Uzawa, Naoki Kawaguchi, Masayuki Masuda, Shingo Konno, Hidekazu Suzuki, Tetsuya Akaishi & Masashi Aoki. (2018) Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan. Journal of Neurology, Neurosurgery & Psychiatry 89:5, pages 513-517.
Crossref
Izabela Monika Rozmilowska & Monika Helena Adamczyk-Sowa. (2018) What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?. Journal of Neuroimmunology 315, pages 50-57.
Crossref
Kimiaki Utsugisawa, Yuriko Nagane, Tetsuya Akaishi, Yasushi Suzuki, Tomihiro Imai, Emiko Tsuda, Naoya Minami, Akiyuki Uzawa, Naoki Kawaguchi, Masayuki Masuda, Shingo Konno, Hidekazu Suzuki, Hiroyuki Murai & Masashi Aoki. (2017) Early fast‐acting treatment strategy against generalized myasthenia gravis. Muscle & Nerve 55:6, pages 794-801.
Crossref
Tetsuya Akaishi, Yasushi Suzuki, Tomihiro Imai, Emiko Tsuda, Naoya Minami, Yuriko Nagane, Akiyuki Uzawa, Naoki Kawaguchi, Masayuki Masuda, Shingo Konno, Hidekazu Suzuki, Hiroyuki Murai, Masashi Aoki & Kimiaki Utsugisawa. (2016) Response to treatment of myasthenia gravis according to clinical subtype. BMC Neurology 16:1.
Crossref
Güher Saruhan-Direskeneli, Travis Hughes, Vuslat Yilmaz, Hacer Durmus, Adam Adler, Mahdi Alahgholi-Hajibehzad, Fikret Aysal, Sibel P. Yentür, Mehmet Ali Akalin, Oner Dogan, Alexander Marx, Yesim Gülsen-Parman, Piraye Oflazer, Feza Deymeer & Amr H. Sawalha. (2016) Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clinical Immunology 166-167, pages 81-88.
Crossref
Rada Miskovic, Aleksandra Plavsic, Aleksandra Peric-Popadic, Sanvila Raskovic & Mirjana Bogic. (2015) Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome after Thymectomy for Myasthenia Gravis - A Case Report. Open Access Macedonian Journal of Medical Sciences 3:3, pages 439-442.
Crossref
Hui-yu Feng, Li-xuan Yang, Wei-bin Liu, Xin Huang, Li Qiu & Yan Li. (2015) The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population. Neurological Sciences 36:7, pages 1135-1140.
Crossref
Kimiaki Utsugisawa, Yuriko Nagane, Tomihiro Imai, Masakatsu Motomura, Masayuki Masuda, Shingo Konno & Shigeaki Suzuki. (2015) Treatment of myasthenia gravis patients with calcineurin inhibitors in Japan: A retrospective analysis of outcomes. Clinical and Experimental Neuroimmunology 6:2, pages 195-200.
Crossref
Tomihiro Imai, Shigeaki Suzuki, Emiko Tsuda, Yuriko Nagane, Hiroyuki Murai, Masayuki Masuda, Shingo Konno, Yasushi Suzuki, Shunya Nakane, Kazuo Fujihara, Norihiro Suzuki & Kimiaki Utsugisawa. (2015) Oral corticosteroid therapy and present disease status in myasthenia gravis. Muscle & Nerve 51:5, pages 692-696.
Crossref
Hiroyuki Murai. (2015) J apanese clinical guidelines for myasthenia gravis: Putting into practice . Clinical and Experimental Neuroimmunology 6:1, pages 21-31.
Crossref
Kimiaki Utsugisawa, Shigeaki Suzuki, Yuriko Nagane, Masayuki Masuda, Hiroyuki Murai, Tomihiro Imai, Emiko Tsuda, Shingo Konno, Shunya Nakane, Yasushi Suzuki, Kazuo Fujihara & Norihiro Suzuki. (2014) Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle & Nerve 50:4, pages 493-500.
Crossref
J. B. Andersen, A. T. Heldal, A. Engeland & N. E. Gilhus. (2014) Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurologica Scandinavica 129, pages 26-31.
Crossref
Jan J.G.M. Verschuuren, Maartje G. Huijbers, Jaap J. Plomp, Erik H. Niks, Peter C. Molenaar, Pilar Martinez-Martinez, Alejandro M. Gomez, Marc H. De Baets & Mario Losen. (2013) Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmunity Reviews 12:9, pages 918-923.
Crossref
Yuriko Nagane. (2013) Clinical factors affecting quality of life and treatment targets in patients with myasthenia gravis. Rinsho Shinkeigaku 53:11, pages 1299-1302.
Crossref
Guo-Yan Qi, Peng Liu & Bu-Lang Gao. (2013) Shenqi Fuzheng Injection Alleviates the Transient Worsening Caused by Steroids Pulse Therapy in Treating Myasthenia Gravis. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-7.
Crossref
Nils Erik Gilhus. (2012) Advances in the treatment of myasthenia gravis. Future Neurology 7:6, pages 701-708.
Crossref
Masayuki masuda, Kimiaki Utsugisawa, Shigeaki Suzuki, Yuriko Nagane, Chiaki Kabasawa, Yasushi Suzuki, Yuko Shimizu, Hiroya Utsumi, Kazuo Fujihara, Shinichiro Uchiyama & Norihiro Suzuki. (2012) The MG-QOL15 Japanese version: Validation and associations with clinical factors. Muscle & Nerve 46:2, pages 166-173.
Crossref
Kenneth R. DeVault & Sami R. Achem. 2012. The Esophagus. The Esophagus 782 813 .
Nils Erik Gilhus. (2011) Acute treatment for myasthenia gravis. Nature Reviews Neurology 7:3, pages 132-134.
Crossref
Nils Erik Gilhus, Jone F. Owe, Jana Midelfart Hoff, Fredrik Romi, Geir Olve Skeie & Johan A. Aarli. (2011) Myasthenia Gravis: A Review of Available Treatment Approaches. Autoimmune Diseases 2011, pages 1-6.
Crossref
Ryan Ramanujam, Yaofeng Zhao, Ritva Pirskanen & Lennart Hammarström. (2010) Lack of association of the CIITA-168A→G promoter SNP with myasthenia gravis and its role in autoimmunity. BMC Medical Genetics 11:1.
Crossref
Maria Elena Farrugia & Angela Vincent. (2010) Autoimmune mediated neuromuscular junction defects. Current Opinion in Neurology 23:5, pages 489-495.
Crossref
Fredric Cantor. (2010) Central and Peripheral Fatigue: Exemplified by Multiple Sclerosis and Myasthenia Gravis. PM&R 2:5, pages 399-405.
Crossref
John E. Greenlee. (2010) Treatment of Paraneoplastic Neurologic Disorders. Current Treatment Options in Neurology 12:3, pages 212-230.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.